Karsten Brand
Impact in
- Oncology top 2%
- Cancer Cells and Metastasis
- CAR-T cell therapy research
- Cancer-related Molecular Pathways
- Cancer Research top 5%
- Protease and Inhibitor Mechanisms
Papers in
- Oncology 27
- Peptidase Inhibition and Analysis 7
- Cancer Cells and Metastasis 4
- Colorectal Cancer Treatments and Studies 4
- CAR-T cell therapy research 4
- Co-authors
- Marja Jäättelä (3 shared papers)Jesper Nylandsted (3 shared papers)Mikkel Rohde (2 shared papers)Lone Bastholm (1 shared paper)Folmer Elling (1 shared paper)Peter Schirmacher (9 shared papers)Jürgen Weitz (8 shared papers)Obul Reddy Bandapalli (10 shared papers)
- Journals
- Cancer Gene Therapy (2 papers)OncoImmunology (2 papers)Gene Therapy (2 papers)Langenbeck s Archives of Surgery (2 papers)Cancer Research (2 papers)
- Partner nations
- GermanyUnited StatesDenmark
In The Last Decade
Karsten Brand
45 papers receiving 2.5k citations
Peers
Comparison fields: 5 of 106
- Oncology 1.1k
- Cancer Research 486
- Immunology 495
- Biotechnology 183
- Molecular Biology 1.4k
Countries citing papers authored by Karsten Brand
This map shows the geographic impact of Karsten Brand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karsten Brand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karsten Brand more than expected).
Fields of papers citing papers by Karsten Brand
This network shows the impact of papers produced by Karsten Brand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karsten Brand. The network helps show where Karsten Brand may publish in the future.
Co-authors
The 25 scholars most cited alongside Karsten Brand, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 45 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2000 | 333 | |
| 2 | 2011 | 232 | |
| 3 | 2011 | 225 | |
| 4 | 1997 | 192 | |
| 5 | 2000 | 153 | |
| 6 | 2007 | 128 | |
| 7 | Eradication of glioblastoma, and breast and colon carcinoma xenografts by Hsp70 depletion. | 2002 | 120 |
| 8 | Liver-associated toxicity of the HSV-tk/GCV approach and adenoviral vectors. | 1997 | 104 |
| 9 | 2002 | 90 | |
| 10 | Treatment of colorectal liver metastases by adenoviral transfer of tissue inhibitor of metalloproteinases-2 into the liver tissue. | 2000 | 88 |
| 11 | 2011 | 70 | |
| 12 | 2011 | 69 | |
| 13 | 1999 | 63 | |
| 14 | 2009 | 54 | |
| 15 | 1998 | 53 | |
| 16 | 2002 | 52 | |
| 17 | 2016 | 48 | |
| 18 | 2012 | 44 | |
| 19 | 2013 | 38 | |
| 20 | 2010 | 33 |
About Karsten Brand
Karsten Brand is a scholar working on Oncology, Molecular Biology, Cancer Research, Genetics and Biotechnology, having authored 45 papers that have together received 2.5k indexed citations. Recurring topics across this work include Virus-based gene therapy research (8 papers), Cancer Research and Treatments (7 papers), Peptidase Inhibition and Analysis (7 papers), Protease and Inhibitor Mechanisms (7 papers), Cancer Cells and Metastasis (4 papers), Immunotherapy and Immune Responses (4 papers), Colorectal Cancer Treatments and Studies (4 papers) and CAR-T cell therapy research (4 papers). The work is most often cited by research in Oncology (1.1k citations), Cancer Research (486 citations), Immunology (495 citations), Biotechnology (183 citations) and Molecular Biology (1.4k citations). Karsten Brand has collaborated with scholars based in Germany, United States and Denmark. Frequent co-authors include Marja Jäättelä, Jesper Nylandsted, Mikkel Rohde, Lone Bastholm, Folmer Elling, Peter Schirmacher, Jürgen Weitz, Obul Reddy Bandapalli, Moritz Koch and W. Arnold. Their work appears in journals such as Cancer Gene Therapy, OncoImmunology, Gene Therapy, Langenbeck s Archives of Surgery and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.